Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Non-Small Cell Lung Cancer
In brief
The primary purpose of the study was to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages II -IIIA according to the 8th edition of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) and the subset of IIIB (T\>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).
Key facts
- Study ID
- NCT03447769
- Run by
- Novartis Pharmaceuticals
- People needed
- 1382
- Starts
- 2018-03-16
- Expected to finish
- 2023-02-07
- Last updated by the study team
- 2024-10-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer and Blood Specialty Clinic — Los Alamitos, California, United States
- University of California at Los Angeles — Los Angeles, California, United States
- VA Palo Alto Health Care System CRLX030A2301 — Palo Alto, California, United States
- Sansum Clinic — Santa Barbara, California, United States
- Rocky Mountain Cancer Centers Denver-Mdtn(Bone&MarrowTransp) — Longmont, Colorado, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- Advanced Medical Specialties Drug Ship - 2 — Miami, Florida, United States
- Florida Cancer Affiliates of Ocala — Ocala, Florida, United States
- Florida Cancer Specialists North — St. Petersburg, Florida, United States
- Florida Cancer Specialists — West Palm Beach, Florida, United States
- Rush University Medical Center Regulatory — Chicago, Illinois, United States
- Cancer Center of Kansas Dept.ofCancerCtr.ofKansas — Wichita, Kansas, United States
- VA Nebraska-W IA Health Care System . — Omaha, Nebraska, United States
- Louis Stokes Cleveland Department of Veterans Affairs MC . — Cleveland, Ohio, United States
- Oncology Associates of Oregon, PC — Eugene, Oregon, United States
- Chattanooga Oncology and Hematology Associates PC Chattanooga Oncology — Chattanooga, Tennessee, United States
- Sarah Cannon Research Institute — Nashville, Tennessee, United States
- Texas Oncology MamieMcFaddenWardCtr — Dallas, Texas, United States
- Virginia Cancer Specialists Fairfax Northern Virginia — Fairfax, Virginia, United States
- Oncology and Hematology Associates of Southwest Virginia Inc . — Salem, Virginia, United States
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — Mar del Plata, Buenos Aires, Argentina
- Novartis Investigative Site — Rosario, Santa Fe Province, Argentina
- Novartis Investigative Site — Rosario, Sante Fe, Argentina
- Highlands Oncology Group . — Fayetteville, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.